New drug trial offers hope for advanced melanoma patients out of options
NCT ID NCT05529316
Summary
This study is testing an experimental drug called botensilimab, alone and in combination with another drug, for people with advanced skin cancer (melanoma) that has continued to grow despite previous immunotherapy treatments. The goal is to see if the new treatment can shrink tumors and control the cancer. About 150 adults with advanced melanoma that has spread or cannot be surgically removed will participate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Hopital Saint-Louis
Paris, 75010, France
-
Azienda Ospedaliero Universitaria Senese
Siena, 53100, Italy
-
Blokhin National Medical Research Oncology Centre
Moscow, 115478, Russia
-
Branch Office of "Hadassah Medical Ltd"
Moscow, 121205, Russia
-
CHU Amiens Picardie - Hopital Sud
Amiens, 80054, France
-
CHU Grenoble-Alpes - Hopital Michallon
La Tronche, 38700, France
-
CHU de Nantes
Nantes, 44093, France
-
CHUV - Centre hospitalier universitaire vaudois
Lausanne, 1011, Switzerland
-
Centre Eugene Marquis
Rennes, 35042, France
-
Centre Leon Berard
Lyon, 69008, France
-
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa
Porto Alegre, 90110-270, Brazil
-
Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho
Jaú, 17210-080, Brazil
-
Clinical Hospital Russian Railways - Medicine
Saint Petersburg, 195271, Russia
-
Consorcio Hospital General Universitario de Valencia
Valencia, 46014, Spain
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20057, United States
-
Gustave Roussy
Villejuif, France
-
Hospital A.C. Camargo Cancer Center
São Paulo, 01509-010, Brazil
-
Hospital Clinic Barcelona
Barcelona, 8036, Spain
-
Hospital General Universitario Gregorio Maranon
Madrid, 28007, Spain
-
Hospital Sirio Libanes
São Paulo, 01308-050, Brazil
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 8035, Spain
-
Hospital Universitario Virgen Macarena
Seville, 41009, Spain
-
INCA II - Instituto Nacional de Cancer Jose Alencar Gomes da Silva
Rio de Janeiro, 20220-410, Brazil
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l.
Meldola, 47014, Italy
-
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, 80131, Italy
-
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Klinikum der Universitaet München
München, 80377, Germany
-
LLC Medical Services
Saint Petersburg, 194356, Russia
-
Moscow City Oncology Hospital #62
Moscow, 143423, Russia
-
Mount Vernon Cancer Centre
Middlesex, HA6 2RN, United Kingdom
-
Oncosite - Centro de Pesquisa Clinica Em Oncologia
Ijuí, 98700-000, Brazil
-
Onkologikoa
Donostia / San Sebastian, 20014, Spain
-
Petrov National Medical Research Center of Oncology
Saint Petersburg, 197758, Russia
-
Providence Saint John's Health Center
Santa Monica, California, 90404, United States
-
Real e Benemerita Associaçao Portuguesa de Beneficencia - A Beneficencia Portuguesa de Sao Paulo
São Paulo, 01323-001, Brazil
-
Royal Marsden Foundation Trust
London, SW3 6JJ, United Kingdom
-
Scottsdale Healthcare Hospitals DBA HonorHealth
Scottsdale, Arizona, 85258, United States
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
Universitaetsklinikum Essen
Essen, 45122, Germany
-
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
-
Universitaetsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitaetsklinikum Tuebingen
Tübingen, 72076, Germany
-
Universitaetsklinikum Würzburg
Würzburg, 97080, Germany
-
Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz
Mainz, 55131, Germany
-
Universitaetsspital Zuerich
Zurich, CH-8091, Switzerland
-
Universitair Ziekenhuis Brussel
Jette, 1090, Belgium
-
University Hospital Schleswig-Holstein
Kiel, 24105, Germany
-
Virginia K. Crosson Cancer Center at St. Jude Medical Center
Fullerton, California, 92835, United States
-
Yale University School of Medicine - Yale Cancer Center
New Haven, Connecticut, 06520-8028, United States
Conditions
Explore the condition pages connected to this study.